Online Event
Cell and Gene Therapy 2024
On-Demand
Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.
Webinar
Discover How Raw Materials Identification Testing Should Be
On-Demand
Raw materials identification (RMID) is a crucial regulatory step required before drug manufacturing. Raman spectroscopy is well-suited to making the process simpler, yet some spectrometers are challenged by light-blocking containers or struggle to reach compliance standards.
Webinar
Ask Me Anything: Genetic Analysis in Cell and Gene Therapy
On-Demand
Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.
Webinar
Expanding the PROTACtable Genome Universe of E3 Ligases
On-Demand
Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.
Webinar
Ask Me Anything: CRISPR Genome Editing Technology
On-Demand
Join us for an exclusive opportunity to speak directly with Dr. David Baltimore, a distinguished figure in this field and a Nobel Laureate, as he navigates the complexities of CRISPR genome editing technology.
Webinar
Accelerating Cell Line Development From Transfection to Manufacturing
On-Demand
Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.
The production of a high-quality and productive cell line requires both an expression system which yields high expressing clones and a workflow which allows selection of the highest producing clones.
In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.
The production of a high-quality and productive cell line requires both an expression system which yields high expressing clones and a workflow which allows selection of the highest producing clones.
In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.
Advertisement